IAVI, Merck, and Serum Institute of India Team to Develop Monoclonal Antibodies for COVID-19

ViiV Healthcare announces once-monthly injectable HIV treatment implementation science study positive findings

IncellDx to Study CCR5 Antagonist Maraviroc in a COVID-19 Phase 2 Clinical Trial

First Patient Dosed in Phase 1 Clinical Trial of Second-Generation COVID-19 Vaccine Candidate Delivering Both Spike and Nucleocapsid of SARS-CoV-2

 Janssen Receives Positive CHMP Opinion for Long-Acting Regimen for the Treatment of HIV

AIDS Healthcare Foundation Says US Taxpayers Co-own Moderna's COVID-19 VAX Patent

Johnson & Johnson to distribute 200m doses of COVID-19 vaccine candidate across the EU

Merck Posts Week 96 Data from Phase 2b Study Evaluating Islatravir in Combination with Doravirine in Adults With HIV-1 Infection

Teva Launches First Generic Versions of HIV-1 Treatments Truvada and Atripla Tablets in the US

Clover Biopharmaceuticals Touts Positive Preclinical Data and Updates on Phase 1 Study for its Adjuvanted S-Trimer COVID-19 Vaccine Candidate

Clover Biopharmaceuticals Forms Global Scientific Advisory Board for its COVID-19 Vaccine Programme

Study Finds That Children's Immune Response Protects Against COVID-19

Healthvana Launches Patient Platform to Support CDC's COVID-19 Vaccination Playbook

Experimental Drug Blocks COVID-19 Viral Entry into Lung Cells

Healthvana expands patient platform for COVID-19 test results to include flu and COVID-19 vaccination records and patient follow-up